--- title: "Safeguarding the delivery of pancreatic islets for the treatment of diabetes" id: "874" type: "post" slug: "treatments-for-diabetes" published_at: "2021-12-04T16:58:55+00:00" modified_at: "2025-09-08T11:42:16+00:00" url: "https://innocorepharma.com/news-events/treatments-for-diabetes/" markdown_url: "https://innocorepharma.com/news-events/treatments-for-diabetes.md" taxonomy_category: - "Innovation & Research" --- 04 December 2021 | Innovation & Research # Safeguarding the delivery of pancreatic islets for the treatment of diabetes InnoCore participated in the DRIVE consortium to develop **D**iabetes-**R**eversing **I**mplants for enhanced **V**iability and long-term**E**fficacy. Data published showed that the combination of SynBiosys®-based VEGF microspheres, exhibiting a continuous release of bioactive VEGF, and an islet encapsulation device encourages the formation of stable and mature blood vessels without exacerbating foreign body response. For more information about the published data visit [https://www.mdpi.com/1999-4923/13/12/2077](https://www.mdpi.com/1999-4923/13/12/2077) Related insights [26 July 2018 | Funding InnoCore and Merck enter global collaboration Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology. Read the full story](https://innocorepharma.com/news-events/innocore-and-merck-enter-global-collaboration/) [11 September 2020 | Funding Bill & Melinda Gates Foundation Grant Awarded InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant. Read the full story](https://innocorepharma.com/news-events/innocore-awarded-grant-by-the-bill-melinda-gates-foundation-in-contraception/) [01 January 2021 | Funding InnoCore leads Consortium in Influenza vaccines InnoCore Pharmaceuticals has secured funding from the European Regional Development Fund to develop a biodegradable polymer-based microneedle array patch. Read the full story](https://innocorepharma.com/news-events/innocore-leads-consortium-in-influenza-vaccines/)